←Back to Expert Scholars
Translational Medicine / 转化医学GVHD, Chronic GVHD Management
Daniel Wolff
MD
🏢University Hospital Regensburg🌐Germany
Professor of Hematology
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Daniel Wolff co-leads international NIH consensus efforts on chronic GVHD staging and response criteria. He chairs the EBMT transplant complications working party and runs multicenter chronic GVHD trials. His work standardizes European GVHD management.
Share:
🧪Research Fields 研究领域
chronic GVHD
NIH consensus
GVHD staging
allogeneic HCT
European GVHD research
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Daniel Wolff 的研究动态
Follow Daniel Wolff's research updates
留下邮箱，当我们发布与 Daniel Wolff（University Hospital Regensburg）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment